Btk overexpression in mature B cells is sufficient to induce autoimmunity. (A) Intracellular flow cytometric Btk detection in splenic CD19+ B cells, shown as histogram overlays from Btk−/− (shaded histogram), WT (black line), and MHCII-hBtk (green line) mice. (B) Immunohistochemical analysis of CD21+ B cells (red), MOMA-1+ metallophilic macrophages (blue; left panel) and GL7+ GC B cells (red), and CD138+ plasma cells (blue; right panel) in the spleens of young (10-14 weeks) MHCII-hBtk mice. (C) Flow cytometric quantification of splenic IgM+ and IgG+ plasma cell numbers in young MHCII-hBtk mice and nontransgenic littermates (WT). (D) WT (black line) and MHCII-hBtk (green line) B cells were stimulated with α-IgM F(ab′)2 fragments and Ca2+ mobilization was monitored and normalized for maximum influx on stimulation with ionomycin. Plots are representative for 4 mice of each genotype. (E) HEp2 reactivity of serum IgG antibodies in aging MHCII-hBtk mice. Percentages indicate proportion of HEp2 reactive serum samples per group (objective 40×). (F) Quantification of IgG antinucleosome and anti-dsDNA autoantibodies in the indicated mice, as determined by ELISA. (G) IgG immune complex deposition in glomeruli, detected by immunohistochemistry on kidney tissue sections from old (> 40 weeks) MHCII-hBtk mice. (H) Immunohistochemical analysis for dendritic cells (CD11c+, red) and B cells (B220+, blue; left panel), GC B cells (PNA+, red) and T cells (CD3+, blue; middle panel), or GC B cells (PNA+, red) and IgG1+ plasma cells (IgG1+, blue; right panel) in lungs from old MHCII-hBtk mice (objective 10×). Data are representative of 6 MHCII-hBtk mice.